Effectdossier · gearchiveerd kwartaal
BEAM
Beam Therapeutics Inc. · Healthcare · Biotechnology
14Gevolgde houders
0Δ houders
51.27MGehouden aandelen
$872.17MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -0.1% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +9 | 71.47M | $2.45B | +12 | −3 |
| Q1 2026 | 92 | +3 | 70.17M | $1.67B | +9 | −6 |
| Q4 2025 | 89 | +3 | 73.41M | $2.04B | +4 | −1 |
| Q3 2025 | 16 | -1 | 52.77M | $1.28B | +1 | −2 |
| Q2 2025 | 14 | 0 | 51.27M | $872.17M | +1 | −1 |
| Q1 2025 | 11 | -2 | 20.67M | $403.69M | — | −2 |
| Q4 2024 | 13 | +2 | 16.59M | $411.47M | +3 | −1 |
| Q3 2024 | 10 | -1 | 11.89M | $291.41M | — | −1 |
| Q2 2024 | 11 | — | 12.82M | $300.27M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 12.96M | — | $220.47M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 9.71M | — | $165.10M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 8.85M | +4.3% | $150.50M | 1.1% | ▲ Add | 5 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (passief) | 8.00M | — | $136.13M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (passief) | 3.64M | +5.8% | $61.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | T. Rowe Price ✦ | 2.44M | -19.3% | $41.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 2.44M | -19.3% | $41.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 2.34M | -6.5% | $39.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 2.34M | -6.5% | $39.76M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Geode Capital Management ✦ (passief) | 2.25M | +2.5% | $38.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Geode Capital Management ✦ (passief) | 2.25M | +2.5% | $38.35M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 561.52K | +52.1% | $9.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Baillie Gifford ✦ | 300.14K | -0.9% | $5.11M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Marshall Wace ✦ | 99.96K | -62.9% | $1.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 42 | Millennium Management ✦ | 58.20K | +59.5% | $990,050 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | Wellington Management ✦ | 37.27K | +10.8% | $633,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 25.42K | Nieuw | $432,411 | 0.0% | New | 1 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 25.42K | Nieuw | $432,411 | 0.0% | New | 1 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 25.42K | Nieuw | $432,411 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| AQR Capital Management | $432,411 | 0.0% |
| AQR Capital Management | $432,411 | 0.0% |
| AQR Capital Management | $432,411 | 0.0% |
Verlaten
| Renaissance Technologies | $236,450 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 248 houders, 107.79M aandelen, $2.49B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API